Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care

Overview

Trimodal prehabilitation is a preoperative three-tiered (trimodal) approach to optimizing physical and mental health. It has been found to successfully improve functional recovery in patients undergoing colorectal surgery following an evidence-based enhanced-recovery pathway (ERP). It is unknown whether the same program is effective in patients undergoing a similar surgery for bladder cancer (radical cystectomy). Objective: To evaluate the appropriateness of a standardized prehabilitation program for implementation into an enhanced recovery pathway for cystectomy patients and determine whether prehabilitation facilitates earlier recovery of functional capacity. Hypothesis: Prehabilitation will ultimately improve recovery of functional capacity, clinical and patient-centered outcomes in patients undergoing radical cystectomy for bladder cancer. Design: Participants will follow an 8-week trimodal prehabilitation program consisting of exercise therapy combined with nutritional counseling, protein supplementation, and psychological care; they will be compared to a cohort of participants following ERP care alone. Conclusion: The proposal will provide insight into the feasibility and effectiveness of trimodal prehabilitation for radical cystectomy patients and may ultimately lead to improved clinical outcomes and reduced morbidity.

Full Title of Study: “Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care: A Randomized Control Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: January 15, 2019

Interventions

  • Combination Product: Trimodal Prehab & ERP
    • 1-hr daily exercise will be completed a total of 5d/week, of which 2 of these sessions are completed through a community fitness center. Following these sessions, the participant will consume a high-protein oral supplement. Additionally, during the program, participants will be given the option of attending a stress-reduction group and will receive a take-home anxiety-reduction program. They will have access to a physiotherapist, kinesiologist, registered dietitian, and physician throughout the program. The total length of this program is 8-weeks and is timed to occur in the waiting period between the consent for surgery and operation date.
  • Other: No Prehab; ERP Alone
    • 1-hr daily exercise with a self-completed home-exercise program. The participant will be given nutritional education material and a take-home anxiety-reduction program. They will be responsible for maintaining a journal of their activity.

Arms, Groups and Cohorts

  • Experimental: Trimodal Prehab & ERP
    • Trimodal prehab includes: Guided exercise program at Repsol Place in Calgary, Alberta 2x/week, hosted by the Total Cardiology group. Home-exercise program for another 3x/week. Nutritional optimization with a high-protein oral supplement, along with nutritional counseling and access to a Registered Dietitian on site. Anxiety reduction workshop and take-home anxiety reduction program.
  • Active Comparator: No Prehab; ERP Alone
    • The active comparator group will be given a home exercise program, nutrition education, and a take-home anxiety reduction program.

Clinical Trial Outcome Measures

Primary Measures

  • 6-minute walk test (6MWT)
    • Time Frame: Multiple time-points over 20-weeks
    • The 6MWT is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.

Secondary Measures

  • 10-meter walk test (10mWT)
    • Time Frame: Multiple time-points over 20-weeks
    • The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.
  • 30s sit-to-stand test (30CST)
    • Time Frame: Multiple time-points over 20-weeks
    • The 30CST is a measurement that assesses functional lower extremity strength in older adults. It is part of the Fullerton Functional Fitness Test Battery. This test was developed to overcome the floor effect of the 5 or 10 repetition sit to stand test in older adults.
  • Hand-grip dynamometry
    • Time Frame: Multiple time-points over 20-weeks
    • A quantitative and objective measure of isometric muscular strength of the hand and forearm, predictive of overall upper-extremity function.
  • Functional Assessment of Cancer Therapy for Bladder Cancer (FACT-Bl)Questionnaire
    • Time Frame: Collected at beginning and end of 20-week participant involvement period
    • A reliable and valid questionnaire that comprehensively assesses quality of life concerns pertinent to bladder cancer patients.
  • EuroQOL five dimensions (EQ-5D) Questionnaire
    • Time Frame: Collected at beginning and end of 20-week participant involvement period
    • A short, generic quality of life questionnaire
  • Godin Leisure Time Exercise Questionnaire
    • Time Frame: Collected at beginning and end of 20-week participant involvement period
    • A short questionnaire on self-reported physical activity.

Participating in This Clinical Trial

Inclusion Criteria

1. Male or female ≥ 18 years of age at time of consent for surgery. 2. Documentation of bladder cancer diagnosis as evidenced by diagnostic imaging and biopsy. 3. May or may not receive adjuvant therapy. 4. Written informed consent obtained from subject Exclusion Criteria:

1. Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient or adherence to the program. This includes: 1. American Society of Anesthesiologists (ASA) health class status 4-5; 2. Co-morbid medical, physical, and/or mental conditions including dementia, disabling orthopedic and neuromuscular disease, psychosis; 3. Severe cardiac abnormalities, end-stage organ disease, sepsis, or morbid obesity (BMI greater than 35); 2. Undergoing radical cystectomy for a reason other than bladder cancer. 3. Poor comprehension of English or French 4. Screened by Total Cardiology staff and determined to be inappropriate for prehabilitation at their facility.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Jason Martyn
  • Collaborator
    • Alberta Health services
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Jason Martyn, Physiotherapist – Alberta Health Services, Calgary
  • Overall Official(s)
    • Jason Martyn, MScPT, Principal Investigator, Alberta Health services
  • Overall Contact(s)
    • Jason Martyn, MScPT, 403-943-3575, jason.martyn@ahs.ca

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.